6/10/2023

Janusmed kön och genus

Janusmed kön och genus – Beklometason

Janusmed kön och genus är ett kunskapsstöd som tillhandahåller information om köns- och genusaspekter på läkemedelsbehandling. Kunskapsstödet är avsedd främst för hälso- och sjukvårdspersonal. Texterna är generella och ska inte ses som behandlingsriktlinjer. Det är alltid behandlande läkare som ansvarar för patientens medicinering.

För att komma till startsidan för Janusmed kön och genus och för att göra sökningar klicka här.

Tillbaka till index
A A
A A

Beklometason

Beklometason

Klass: A

Visa all info

Skriv ut

Kontakta oss

Produkter

Visa alla produkter

AeroBec, AeroBec Autohaler, Beclomet Easyhaler, Becotid......

AeroBec, AeroBec Autohaler, Beclomet Easyhaler, Becotide, Becotide Nasal, Innovair, Innovair nexthaler, Trimbow
ATC-koder

R01AD01, R03AK08, R03AL09, R03BA01

R01AD01, R03AK08, R03AL09, R03BA01
Substanser

Visa alla substanser

beklometason, beklometasondipropionat (vattenfritt), be......

beklometason, beklometasondipropionat (vattenfritt), beklometasondipropionatmonohydrat
Sammanfattning

En subgruppsanalys av en randomiserad kontrollerad studie visade inga könsskillnader i effekt av beklometason nässpray. Det saknas större kontrollerade studier avseende könsskillnader i effekt.

En kohortstudie på barn visade att pojkar som använt kortikosteroider som inhalation hade högre frakturrisk jämfört med flickor. Det saknas publicerade kliniska studier avseende könsskillnader i biverkningar hos barn och vuxna.

En mindre studie fann generellt sämre inhalationsteknik hos kvinnor vilket gav lägre effektiv dos.

En subgruppsanalys av en randomiserad kontrollerad studie visade inga könsskillnader i effekt av beklometason nässpray. Det saknas större kontrollerade studier avseende könsskillnader i effekt. En kohortstudie på barn visade att pojkar som använt kortikosteroider som inhalation hade högre frakturrisk jämfört med flickor. Det saknas publicerade kliniska studier avseende könsskillnader i biverkningar hos barn och vuxna. En mindre studie fann generellt sämre inhalationsteknik hos kvinnor vilket gav lägre effektiv dos.
Background

COPD (chronic obstructive pulmonary disease) affects more women than men and women often get a more serious and rapidly progressive disease [1]. Adult asthma is more common in women while childhood asthma is more common in boys. The reversal of this sex difference in prevalence occurs around puberty which suggests that sex hormones may play a role in the etiology of asthma [2]. However, some studies suggest that there are sex differences in expression and diagnosing of asthma, and it has been discussed if women are under-treated for respiratory diseases or not [3, 4].

Pharmacokinetics and dosing
The influence of sex on the pharmacokinetics of QVAR REDIHALER (beclomethasone dipropionate HFA) has not been studied [5]. 

Effects
In a subgroup analysis of a randomized, double-blind, placebo-controlled study of the efficacy of beclomethasone dipropionate nasal aerosol, no significant sex differences in efficacy were found. However, it was hard to draw conclusions from the subgroup analysis because of the small sample size of the subgroup [6].

Adverse effects
In a population-based coh......

Visa hela bakgrundstexten

COPD (chronic obstructive pulmonary disease) affects more women than men and women often get a more serious and rapidly progressive disease [1]. Adult asthma is more common in women while childhood asthma is more common in boys. The reversal of this sex difference in prevalence occurs around puberty which suggests that sex hormones may play a role in the etiology of asthma [2]. However, some studies suggest that there are sex differences in expression and diagnosing of asthma, and it has been discussed if women are under-treated for respiratory diseases or not [3, 4]. # Pharmacokinetics and dosing The influence of sex on the pharmacokinetics of QVAR REDIHALER (beclomethasone dipropionate HFA) has not been studied [5].  # Effects In a subgroup analysis of a randomized, double-blind, placebo-controlled study of the efficacy of beclomethasone dipropionate nasal aerosol, no significant sex differences in efficacy were found. However, it was hard to draw conclusions from the subgroup analysis because of the small sample size of the subgroup [6]. # Adverse effects In a population-based cohort of children aged 4-17 years in the UK, it was found that the use of inhaled corticosteroids (beclomethasone dipropionate or equivalent) was associated with an increased fracture incidence and the risk of fractures for boys was generally higher than that for girls [7]. # Reproductive health issues Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan). # Other information In a retrospective population-based cohort study  investigating sex-specific drug utilization patterns in pediatric outpatient populations in Italy, no sex differences were found for acute inhaled beclomethasone. However, the prevalence of recurrent use of inhaled beclomethasone was higher in boys. This could suggest greater recurrent asthma episodes/exacerbation in boys and subsequently confirming the relationship between drug intake and prevalence of such disease in boys [8]. In a study on inhalation technique using metered dose inhalers (33 men, 26 women), 75% of the participants had an incorrect inhalation technique, especially women, regardless of age. Only 4% of women and 43% of men had an acceptable inhalation technique. The authors speculate that this may add to the worse asthma prognosis in women, shown in a meta-analysis of six trials of randomly assigned asthma treatment [9]. Several studies have shown worse prognosis for women with asthma. In an observational registry study (416 men, 498 women), women were found to have more asthmatic symptoms, worse quality of life and require more health care due to their asthma [10]. In a Danish prospective study on hospitalization due to asthma (6104 men of whom 2.5% had asthma, 7436 women of whom 2.2% had asthma), women had a 1.7 higher relative risk to be hospitalized [11]. An observational study from Singapore found hospitalization due to asthma to be more common in boys than girls aged 0-4 years (boys/girls ratio 1.69). In adults aged 35-64 years, women were more hospitalized (men/women ratio 0.81) [12].
Försäljning på recept

Visa hela försäljning på recept

Fler kvinnor än män hämtade läkemedel innehållande kombination av beklometason och formoterol (ATC-kod R03AK08) i Sverige år 2019, totalt 17 327 kvinnor och 10 413 män. Det motsvarar 3,4 respektive 2,0 personer per tusen invånare. Andelen som hämtat ut läkemedel var högst i åldersgruppen 75 år och äldre hos båda könen. I åldersgruppen 0-14 år var läkemedel innehållande kombination av beklometason och formoterol i genomsnitt 1,4 gångar vanligare hos män och i åldersgruppen 15 år och äldre 1,6 gånger vanligare hos kvinnor [13]. Fler kvinnor än män hämtade ut inhalationsspray innehållande beklometason (ATC-kod R03AB01) på recept i Sverige år 2019, totalt 2 004 kvinnor och 1 190 män. Det motsvarar 3,9 respektive 2,3 personer per tiotusen invånare. Andelen som hämtat ut läkemedel var högst i åldersgruppen 75 år och äldre hos båda könen. Totalt sett var inhalationsspray innehållande beklometason 1,7 gånger vanligare hos kvinnor [13].
Referenser

Visa referenser

  1. Nationella riktlinjer för vård vid astma och kroniskt obstruktiv lungsjukdom (KOL). Socialstyrelsen. [updated 2018-01-29, cited 2020-09-14].

  2. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019;7:246.

  3. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J. 2006;28:319-22.

  4. Tantisira KG, Colvin R, Tonascia J, Strunk RC, Weiss ST, Fuhlbrigge AL et al. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med. 2008;178:325-31.

  5. QVAR REDIHALER (beclomethasone). DailyMed [www]. [updated 2020-10-14, cited 2020-12-02].

  6. U.S. Food and Drug Administration. Medical Review - QNASL (beclometahosone). Drugs@FDA [www]. [updated 2013-06-10, cited 2020-12-02].

  7. van Staa TP, Bishop N, Leufkens HG, Cooper C. Are inhaled corticosteroids associated with an increased risk of fracture in children?. Osteoporos Int. 2004;15(10):785-91.

  8. Ferrajolo C, Sultana J, Ientile V, Scavone C, Scondotto G, Tari M et al. Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy. Front Pharmacol. 2019;10:11.

  9. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med. 1994;150:1256-61.

  10. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998;157:123-8.

  11. Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population Copenhagen City Heart Study Group. Thorax. 1997;52:287-9.

  12. Ng TP, Niti M, Tan WC. Trends and ethnic differences in asthma hospitalization rates in Singapore, 1991 to 1998. Ann Allergy Asthma Immunol. 2003;90:51-5.

  13. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2019 [cited 2020-03-10.]

  1. Nationella riktlinjer för vård vid astma och kroniskt obstruktiv lungsjukdom (KOL). Socialstyrelsen. [updated 2018-01-29, cited 2020-09-14].
  2. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019;7:246.
  3. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J. 2006;28:319-22.
  4. Tantisira KG, Colvin R, Tonascia J, Strunk RC, Weiss ST, Fuhlbrigge AL et al. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med. 2008;178:325-31.
  5. QVAR REDIHALER (beclomethasone). DailyMed [www]. [updated 2020-10-14, cited 2020-12-02].
  6. U.S. Food and Drug Administration. Medical Review - QNASL (beclometahosone). Drugs@FDA [www]. [updated 2013-06-10, cited 2020-12-02].
  7. van Staa TP, Bishop N, Leufkens HG, Cooper C. Are inhaled corticosteroids associated with an increased risk of fracture in children?. Osteoporos Int. 2004;15(10):785-91.
  8. Ferrajolo C, Sultana J, Ientile V, Scavone C, Scondotto G, Tari M et al. Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy. Front Pharmacol. 2019;10:11.
  9. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med. 1994;150:1256-61.
  10. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998;157:123-8.
  11. Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population Copenhagen City Heart Study Group. Thorax. 1997;52:287-9.
  12. Ng TP, Niti M, Tan WC. Trends and ethnic differences in asthma hospitalization rates in Singapore, 1991 to 1998. Ann Allergy Asthma Immunol. 2003;90:51-5.
  13. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2019 [cited 2020-03-10.]
Uppdaterat

Litteratursökningsdatum 12/2/2020

Litteratursökningsdatum 12/2/2020